SCHEMBL56978

SCHEMBL56978

O=C1c2ccccc2C(=O)N1CCCBr

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GLS O94925 1/20 0.62
TDP1 Q9NUW8 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MAPT P10636 1/20 0.58
RAB9A P51151 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 2/20 0.56
CHRM2 P08172 2/20 0.56
CYP2D6 P10635 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29351736 1.00 GLS (0.62) GLSTDP1L3MBTL1MAPTRAB9A
Hydrochloric Acid SCHEMBL10638625 0.98 GLS (0.60) GLSTDP1L3MBTL1MAPTRAB9A
SCHEMBL29459467 0.94 TDP1 (0.61) GLSTDP1L3MBTL1MAPTRAB9A
SCHEMBL14468 0.94 TDP1 (0.61) GLSTDP1L3MBTL1MAPTRAB9A
SCHEMBL98805 0.92 TDP1 (0.64) TDP1L3MBTL1CYP1A2CYP2C19CHRM2
SCHEMBL4580702 0.92 TDP1 (0.64) TDP1L3MBTL1CYP1A2CYP2C19CHRM2
SCHEMBL876407 0.92 TDP1 (0.64) TDP1L3MBTL1CYP1A2CYP2C19CHRM2
SCHEMBL4579395 0.92 TDP1 (0.64) TDP1L3MBTL1CYP1A2CYP2C19CHRM2
SCHEMBL3986297 0.92 TDP1 (0.64) TDP1L3MBTL1CYP1A2CYP2C19CHRM2
SCHEMBL585441 0.92 TDP1 (0.64) TDP1L3MBTL1CYP1A2CYP2C19CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3431 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP claimed
CN-117143171-B Tripterine derivative containing phthalimide and preparation method and application thereof 井冈山大学 2024-02-06 CN claimed
CN-117143171-A Tripterine derivative containing phthalimide and preparation method and application thereof 井冈山大学 2023-12-01 CN claimed
CN-116514763-A Preparation method and application of fluorescent probe for monitoring redox process 天津理工大学 2023-08-01 CN claimed
CN-116354870-A Method for synthesizing 3-benzyl-1- (tert-butoxycarbonyl) piperidine-3-carboxylic acid 苏州特瑞药业股份有限公司 2023-06-30 CN claimed
CN-113234025-B Salicylaldehyde Schiff base derivative based on ureido pyrimidinone and supramolecular polymer 常州大学 2023-05-09 CN claimed
CN-113968809-A Chemical synthesis method of melatonin 太阳树(莆田)生物医药有限公司 2022-01-25 CN claimed
CN-111116928-B Supermolecule hyperbranched polymer using double drug molecules as basic units and preparation method thereof 西北工业大学 2021-11-12 CN claimed
CN-113234025-A Ureidopyrimidone-based salicylaldehyde Schiff base derivative and supramolecular polymer 常州大学 2021-08-10 CN claimed
CN-112375562-A Cysteine-polyamine-morpholine-modified quantum dot lysosome targeted fluorescent probe and preparation method and application thereof 河南大学 2021-02-19 CN claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
EP-0330625-B1 Total synthesis method for making an indole structure derivative product class, of the triptamine type, in particular, melatonin or N-acetyl-5-methoxytriptamine type, having a high purity degree and easily soluble, for therapeutic use against acquired immuno-deficiency syndromes I F L O S A S DI GIORGIO E ALD (IT) 1995-12-20 EP claimed
EP-0220409-B1 GEM-DIHALO AND TETRAHALO-1,12-DIAMINO-4,9-DIAZA-DODECANES MERRELL DOW PHARMACEUTICALS INC. (US) 1991-11-27 EP claimed
EP-0215319-B1 GEM-DIHALO-1,8-DIAMINO-4-AZA-OCTANES MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-16 EP claimed
US-4914240-A PROTECTING DIHALO BUTANEDIOL, REACTING WITH POTASSIUM PHTHALIMINDE, DEPROTECTING; MULTISTEP MERRELL DOW PHARMACEUTICALS INC. (US) 1990-04-03 US claimed
EP-0220409-A2 Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes MERRELL DOW PHARMACEUTICALS INC. (US) 1987-05-06 EP claimed
EP-0215319-A2 Gem-dihalo-1,8-diamino-4-aza-octanes MERRELL DOW PHARMACEUTICALS INC. (US) 1987-03-25 EP claimed